orexin and binge-like consumption: sucrose, saccharin, ethanol andy deemer
TRANSCRIPT
Orexin and binge-like consumption:
Sucrose, Saccharin, Ethanol
ANDY DEEMER
Bingeing• Eating, Drinking, Drugs
• Orexin plays a role but…• Caloric Status? (Non-)Caloric reward?
• Conditioning? Cue-induced reward seeking
• ♂ ♀ differences?
• Inconsistencies in several studies
• Methodology related? Gender related?
• Gender Differences• Orexin system
• ♀ rat - higher Orexin A and OXR1 in HL than ♂• Responses to food restriction• More studies = more differences revealed.
Economic, Social and Therapeutic Potential of Orexin Research
• Overconsumption of ______________ is a significant public health/economic issue.
• Potential applications in obesity, diabetes, drug abuse
• Understanding factors at play = better therapy
• Caloric restriction important?
• Gender diffs?
• Bingeing substance (caloric/non, hedonic)
• Orexin system sexual dimorphism
• Eating disorders more common in women
• OX system gender differences may play a role
• Hedonic vs Homeostatic
• Saccharin vs sucrose
Cason & Aston-Jones 2014
Role of orexin/hypocretin in conditioned sucrose-seeking in female rats
Methods
• Female Sprague-Dawley rats
• Two Feeding Treatments
• Ad libitum (AL) = free access
• Food-restricted (FR) =
• 1 daily feeding - maintained at 85% of AL body mass)
• Drug = SB-334867 (OXR1 antagonist)• 3 doses used in this study 10, 20, and 30 mg/kg
• Intraperitoneal (4 mL/kg)"SpragueDawleyRat" by Jean-Etienne Minh-Duy Poirrier - http://www.flickr.com/photos/jepoirrier/422469518/in/set-72157594329856603/. Licensed under CC BY-SA 2.0 via Wikimedia Commons - http://commons.wikimedia.org/wiki/File:SpragueDawleyRat.jpg#/media/File:SpragueDawleyRat.jpg
Cason & Aston-Jones 2014
Methods• Training – self-administer sucrose pellets
• Press lever = get sucrose pellet
• Compound cue (light and sound)
• Fixed ratio (FR) 1 responding• Until 10 sessions earning > 9 sucrose pellets
• Progressive ratio (PR) responding• Using mice previously trained from FR experiment
• Find breakpoint for lever presses
Images adapted from: http://rnpsychology.org/demo/index.htm
Cason & Aston-Jones 2014
Fixed vs Progressive Ratio Schedule
Progressive Ratio = 5ePelletNumber*0.2 – 5
Point at which no more rewards are earned over an hour = breakpoint.
Cason & Aston-Jones 2014
Methods - Ratio Experiments
Fixed Ratio:
Train Vehicle/Drug injection Self-administration session
Progressive Ratio:
Use rats from fixed ratio experiment Train Injection
Self-administration session
Each rat was tested at multiple doses (2 doses)
Vehicle/Drug injected 30 minutes prior to
test sessions (all 3 of today’s papers)
Cason & Aston-Jones 2014
Cue-induced reinstatement of sucrose-seeking
• Take mice used for FR1 (but not PR)
• Daily extinction sessions
• Lever presses = nothing happens• Untraining
• Until 2 consecutive sessions with < 25 active lever presses
• Bring cues back (but no sucrose)
• Measure SB effect on presses
• 2 late extinction and 2 reinstatement sessions
Cason & Aston-Jones 2014
Self-Admin Training
• # days to train similar for FR and AL rats
• Food-restricted
• More active and inactive presses + pellets earned
Cason & Aston-Jones 2014
Fixed Ratio Experiment
• FR more active presses + pellets earned
• SD sig. effect on active presses only at high dose
• No sig. effect of SD on pellets earned
Cason & Aston-Jones 2014
Progressive Ratio Experiment
• No effect of group or SB dose on breakpoint
Cason & Aston-Jones 2014
Cue-induced reinstatement of sucrose-seeking
• Food group effect• No sig. SB effect on
CIRSS• Contrary to their previous
findings in ♂ rats
• AL and FR rats met extinction criteria < 5 extinction sessions
• SB attenuation of active presses - late extinction
Cason & Aston-Jones 2014
Cason & Aston-Jones Take Homes
• Cue-induced reinstatement and SB-334867
• Sex-dependent story
• ♀ - OXR1 unnecessary; important in ♂
• Increased extinction responding • Orexin role in learning/reward valuation in females?
• Future Research: • Systems at play in ♀ cue-induced seeking (e.g. leptin, insulin,
ghrelin, estrogen)
• Untangling ♂ ♀ circuitry differences
• SB-334867 effects on Fos expression in orexin targets
Cason & Aston-Jones 2014
Cason & Aston-Jones Take Homes
• Agree with conclusion?
• “Our findings show that OxR1 regulates operant responding for sucrose reinforcement, but not motivation to work…”
• Fig 4, Panel 1:
With OXR1 unblocked, try less = regulates motivation to work?
Cason & Aston-Jones 2014
• Objectives:
• SB-334867 effect on binge consumption of sucrose and saccharin in ad libitum-fed mice
• Effect of repetitive sucrose and saccharin bingeing on OX mRNA expr in LH• Mirror chronic morphine, cocaine, ethanol?
Binge-like consumption of caloric and non-caloric palatable substances in ad libitum-fed C57BL/6J mice: Pharmacological and molecular evidence of orexin involvement
Alcaraz-Iborra et al. 2014
Methods
• Male C57BL/6J (8 wks old @ start)
• Drug = SB-334867 (OXR1 antagonist)
• Intraperitoneal (10 mL/kg)
• Drinking-in-the-Dark (DID) procedure
• High voluntary bingeing on ethanol, sucrose, saccharin during early part of dark cycle
• Provide sucrose/saccharin ~ 3 hrs. into dark cycle
• Open-field activity monitoring
• qPCR
Alcaraz-Iborra et al. 2014
Experiment 1: Effect of SB on sucrose and saccharin binge
drinking• Binge-training / screening
• 3 days of DID (2 hrs bottle access)• ip injection w/ vehicle - habituation
• 4th day = test day (4 hrs bottle access)• Injection of SB (10, 20 or 30 mg/kg) or vehicle 30 min prior to test
• Measure:• Liquid imbibed
• Calories consumed (chow included)
Alcaraz-Iborra et al. 2014
Total calories consumed (kcal/g/4 h) on test day
Sucrose group
(kcal/g)Saccharin group
(kcal/g)VEH 3.47 ± 0.20 2.74 ± 0.42
SB (10 mg) 2.24 ± 0.14** 0.20 ± 0.09**SB (20 mg) 1.11 ± 0.28** 1.24 ± 0.49**SB (30 mg) 0.97 ± 0.19** 0.64 ± 0.39**
*
• ip SB-334867 ↓ sucrose and saccharin bingeing
• Higher doses ↓ sucrose bingeing more than lowest dose
• Strange calories consumed data in saccharin group
Alcaraz-Iborra et al. 2014
Experiment 2: Effect of SB on locomotor activity
• Open-field locomotor activity monitoring• Days 1-3: Habituate to injection (vehicle) and activity chamber & record behavior
• Day 4: 30 mg/kg SB → activity chamber
• Evaluate difference
• Purpose: SB-334867 impact distance traveled and movement time?• Explanation for reduced fluid/food intake?
• Results: No sig. diff.• The means they present seem fairly different, but no sig. diff
Alcaraz-Iborra et al. 2014
Experiment 3: Repeated sucrose/saccharin bingeing and mRNA expression
in the HL
• Repeated bingeing (DID – i.e. voluntary)• Four 2-hour daily binge sessions
• Sucrose, Saccharin, or Water group
• Brain dissection → LH removed → RNA extracted
• qPCR with GAPDH for comparison
Alcaraz-Iborra et al. 2014
Consumption data (ml/kg/2 h) associated with the mRNA study.
Water consumption (ml/kg/2 h)
Sucrose consumption (ml/kg/2 h)
Saccharin consumption (ml/kg/2 h)
Day 1 34.40 ± 0.64 72.42 ± 8.78 67.70 ± 6.86
Day 2 23.42 ± 3.50 117.72 ± 10.46 94.41 ± 15.24
Day 3 22.14 ± 0.87 125.80 ± 4.16 77.88 ± 6.87
Day 4 21.12 ± 2.29 103.74 ± 8.07 86.69 ± 3.64
• Repeated bingeing ↓ HL OX mRNA
• Sucrose group: 5x > water intake
Alcaraz-Iborra et al. 2014
Alcaraz-Iborra et al. 2014: Take-homes
• OXR1 role in caloric bingeing in AL-fed animals
• SB-334867 ↓ caloric & non-caloric bingeing in AL-fed ♂ mice
• Unclear why in AL-fed mice (ip injection)• Future Research: Site-directed SB studies
• 1st evidence of OXR1 role in non-caloric bingeing/hedonic overconsumption
• Repeated daily bingeing ↓ HL OX expr (qPCR)
Alcaraz-Iborra et al. 2014: Take-homes
• SB effect on bingeing not caused by SB-altered locomotion.
• Why not show more data?
• DID potential issue:
• Energy status at time of DID
• Future Research: Alter energy status during DID
Binge-like consumption of Ethanol and Other Salient Reinforcers is Blocked by
Orexin-1 Receptor Inhibition and Leads to a Reduction in Hypothalamic Orexin
Immunoreactivity
Olney et al. 2015
Illustration by Emily Coren.
Purpose
• Characterize OXR1 role in “binge” drinking
• Ethanol, sucrose, saccharin
• Binge-like EtOH and Sucrose drinking
• Effect on OX immunoreactivity in HL
• Effect of ip SB
• SB specificity for EtOH modulation
• Compare with saccharin bingeing
Olney et al. 2015
Methods
• C57BL/6J male mice (7-9 wks old)
• SB-334867 (0, 5, 10 mg/kg)
• Bingeing cycles:
• 1 or 3 cycles; EtOH or Sucrose
• DID (modified 2 hrs not 4 – short drug action)
• Except experiment 1 – used 4 hrs.
• Blood alcohol content
• Brain dissection
• Orexin A immunoreacitivy (LH and PFA)
Olney et al. 2015
Methods
• SB ip injection
• Reduced EtOH consumption? Saccharin?
• Each mouse, all doses• 4 day cycle with 3 days rest between doses
• Locomotion
• Open field test with Saccharin group mice
• 2 hours
• 0 or 10 mg/kg SB
Olney et al. 2015
Olney et al. 2015
• No cycle effect on:
• EtOH Consump.• Sucrose Consump• BEC
• EtOH bingeing ↓ LH OX levels
Olney et al. 2015
EtOH Bingeing reduced HL OX
Olney et al. 2015
• SB ↓ EtOH consumption• Short-lived (Hr 1 vs. Hr 2)• BEC levels parallel total consumption
• SB ↓ Saccharin consumption• Only signif. largest dose over 2 hrs.
• Take Home: SB effect on ↓ bingeing not specific to EtOH or caloric foods
Olney et al. 2015
Locomotion
• Like Alcaraz-Iborra: • SB-induced general lethary
cause of reduced bingeing?
• Open field test: • No impairment of
locomoter activity
Olney et al. 2015: Take-homes• OXR1 role in caloric and non-caloric bingeing
• Not EtOH specific
• Bingeing ↓ HL OXR1
• SB effects not due to altered locomotion
• DID 4hr vs 2hr
• Duration of drug effect may be less than 4 hrs
• Inconsistent dose effects between researchers• SB variability: Supplier effects, batch effects
• Future Research:
• Mechanisms responsible for post-binge OX and OXR1 levels
• Interplay of dynorphin and OX w/in VTA
Overall Take-homes
Site-specific studies necessary (not ip injection)
- ID OX circuits underlying phenomena
- VTA likely involved
Thank You!